Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Johnson & Johnson (

Getting vaccinated this holiday season? Here’s how to stay up-to-date on your COVID shots

DALLAS — Staying on schedule with the COVID-19 vaccine can feel like chasing a moving target.

Tribune News Service

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

Al Jazeera

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

Investors Business Daily

Pelvic mesh victims left unsure of futures as legal fees threaten to slash class action payout

The legal firm representing the thousands of plaintiffs in a class action over dangerous pelvic mesh could take up to a third of the compensation payment.

ABC News

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

‘The vagina is self-cleaning’ – so why do companies push hygiene products on Black women?

Racist advertising practices marketed vaginal cleansing products to Black women. Years later, they deal with the fallout

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

The Blockbuster Potential That Sent IBD Stock Of The Day Halozyme Into A Breakout

IBD Stock Of The Day Halozyme is entering a new wave of development — leading HALO stock to surge into a breakout Wednesday.

Investors Business Daily

Asian benchmarks mixed as markets await Fed rate moves

Asian shares are mixed while Chinese shares surged ahead of a decision by the U.S. Federal Reserve on an interest rate increase to curb inflation

The Independent UK

Johnson & Johnson Whale Trades Spotted

Benzinga

United Airlines, Johnson & Johnson And 2 Other Stocks Insiders Are Selling

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

Johnson & Johnson Notches Quarterly Beat, Outplaying Exchange-Rate Headwinds

Johnson & Johnson topped third-quarter expectations on Thursday despite exchange-rate challenges, but JNJ stock pared back gains.

Investors Business Daily

Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18

Reuters Exxon Exits Russia Completely After Putin Seizes Company's Properties

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Surges 600 Points As Goldman, J&J Report Earnings; Netflix Earnings Due

The Dow Jones Industrial Average surged Tuesday, as Goldman Sachs and J&J reported earnings results. Netflix earnings are due out late.

Benzinga

Earnings Season Is Here: Tesla, Netflix, IBM, AT&T And More On Deck - But This Stock Could Be 'Most Important'

The week of Oct. 17 is one of the busiest weeks for publicly traded companies reporting quarterly earnings.

Benzinga

What Are Whales Doing With Johnson & Johnson

Benzinga

Johnson & Johnson Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 15 strange trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

St. Louis Post-Dispatch

Editorial: Alex Jones tries to hide his riches from the people whose lives he destroyed

As if to boost the brand of the League of Unrepentant Evildoers, Infowars founder Alex Jones has tried to join the likes of Purdue Pharma, Johnson & Johnson and the National Rifle Association in declaring bankruptcy as a way to evade multimillion-dollar court judgments against him. Jones is in the…

Benzinga

Looking At Johnson & Johnson's Recent Whale Trades

Chicago Tribune

Movement in the Tylenol murders: Law enforcement seeks to persuade prosecutors to act on ‘chargeable’ case

CHICAGO — As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

The Conversation

Action on faulty vaginal mesh took too long, now women struggle to access mesh surgery that works

Last week, Johnson Johnson reached a A$300 million settlement for two class actions brought by Australian women affected by complications from vaginal mesh products.

WEKU

J&J tried to block lawsuits from 40,000 cancer patients. A court wants answers

Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

Newcastle Herald

Pelvic mesh class action $300m payout: but who will get the money?

Further details about the Johnson & Johnson class action are expected to emerge on Friday

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.